These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8840280)

  • 1. Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy.
    Langub MC; Koszewski NJ; Turner HV; Monier-Faugere MC; Geng Z; Malluche HH
    Kidney Int; 1996 Aug; 50(2):515-20. PubMed ID: 8840280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
    Hoyland JA; Freemont AJ; Sharpe PT
    J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
    Franchimont N; Durant D; Canalis E
    Endocrinology; 1997 Aug; 138(8):3380-6. PubMed ID: 9231791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.
    Udagawa N; Takahashi N; Katagiri T; Tamura T; Wada S; Findlay DM; Martin TJ; Hirota H; Taga T; Kishimoto T; Suda T
    J Exp Med; 1995 Nov; 182(5):1461-8. PubMed ID: 7595216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone.
    Ohsaki Y; Takahashi S; Scarcez T; Demulder A; Nishihara T; Williams R; Roodman GD
    Endocrinology; 1992 Nov; 131(5):2229-34. PubMed ID: 1425421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast function in Paget's disease and multiple myeloma.
    Roodman GD
    Bone; 1995 Aug; 17(2 Suppl):57S-61S. PubMed ID: 8579899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M; Richards CD; Gauldie J
    Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P; Persson E; Conaway HH; Lerner UH
    J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption.
    Adebanjo OA; Moonga BS; Yamate T; Sun L; Minkin C; Abe E; Zaidi M
    J Cell Biol; 1998 Sep; 142(5):1347-56. PubMed ID: 9732294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha).
    März P; Gadient RA; Otten U
    Brain Res; 1996 Jan; 706(1):71-9. PubMed ID: 8720493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
    Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
    J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of interleukin-6 and soluble interleukin-6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro.
    Flanagan AM; Stow MD; Williams R
    J Pathol; 1995 Jul; 176(3):289-97. PubMed ID: 7674091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat.
    Shizuya K; Komori T; Fujiwara R; Miyahara S; Ohmori M; Nomura J
    Life Sci; 1997; 61(10):PL 135-40. PubMed ID: 9296342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta.
    Vallières L; Rivest S
    J Neurochem; 1997 Oct; 69(4):1668-83. PubMed ID: 9326296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclasts in normal and adjuvant arthritis bone tissues express the mRNA for both type I and II interleukin-1 receptors.
    Xu LX; Kukita T; Nakano Y; Yu H; Hotokebuchi T; Kuratani T; Iijima T; Koga T
    Lab Invest; 1996 Nov; 75(5):677-87. PubMed ID: 8941213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
    Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
    Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
    Oh JW; Revel M; Chebath J
    Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
    Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
    Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.
    O'Keefe RJ; Teot LA; Singh D; Puzas JE; Rosier RN; Hicks DG
    Lab Invest; 1997 Apr; 76(4):457-65. PubMed ID: 9111508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.